Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakub Tomala

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Oncoimmunology|May 4, 2016
IL-2/anti-IL-2 mAb immunocomplexes: A renascence of IL-2 in cancer immunotherapy?Jakub Tomala, Marek Kovar
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2020
Characterization of Immune Cell Subset Expansion in Response to Therapeutic Treatment in MiceJakub Tomala, Jamie B Spangler
Immunology Letters|February 12, 2014
Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimeraPetra Votavova, Jakub Tomala, Marek Kovar
Journal of Immunology (Baltimore, Md. : 1950)|January 2, 2024
Engineering Anticytokine Antibodies for Immune ModulationJakub Tomala, Shanelle D Cao, Jamie B Spangler
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2009
In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapyJakub Tomala, Helena Chmelova, Tomas Mrkvan, et al.
Cytokine|June 30, 2020
IL-7/αIL-7 mAb M25 immunocomplexes expand CD8<sup>+</sup> T cells but paradoxically abrogate the antitumor activity of CTLA-4 and PD-1 blockageDominik Hrabos, Tereza Hnizdilova, Jakub Tomala, et al.
Journal of Drug Targeting|October 11, 2011
Synergistic effect of EMF-BEMER-type pulsed weak electromagnetic field and HPMA-bound doxorubicin on mouse EL4 T-cell lymphomaBlanka Říhová, Tomáš Etrych, Milada Šírová, et al.
Oncoimmunology|June 23, 2017
Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cellsIrena Adkins, Lenka Sadilkova, Nada Hradilova, et al.
International Journal of Cancer|December 18, 2010
Antitumor activity of IL-2/anti-IL-2 mAb immunocomplexes exerts synergism with that of N-(2-hydroxypropyl)methacrylamide copolymer-bound doxorubicin conjugate due to its low immunosuppressive activityJakub Tomala, Helena Chmelova, Jiri Strohalm, et al.
Journal of Biomedical Nanotechnology|October 22, 2015
Novel IL-2-Poly(HPMA)Nanoconjugate Based ImmunotherapyPetra Votavova, Jakub Tomala, Vladimir Subr, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Oncoimmunology|May 4, 2016
IL-2/anti-IL-2 mAb immunocomplexes: A renascence of IL-2 in cancer immunotherapy?Jakub Tomala, Marek Kovar
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2020
Characterization of Immune Cell Subset Expansion in Response to Therapeutic Treatment in MiceJakub Tomala, Jamie B Spangler
Immunology Letters|February 12, 2014
Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimeraPetra Votavova, Jakub Tomala, Marek Kovar
Journal of Immunology (Baltimore, Md. : 1950)|January 2, 2024
Engineering Anticytokine Antibodies for Immune ModulationJakub Tomala, Shanelle D Cao, Jamie B Spangler
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2009
In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapyJakub Tomala, Helena Chmelova, Tomas Mrkvan, et al.
Cytokine|June 30, 2020
IL-7/αIL-7 mAb M25 immunocomplexes expand CD8<sup>+</sup> T cells but paradoxically abrogate the antitumor activity of CTLA-4 and PD-1 blockageDominik Hrabos, Tereza Hnizdilova, Jakub Tomala, et al.
Journal of Drug Targeting|October 11, 2011
Synergistic effect of EMF-BEMER-type pulsed weak electromagnetic field and HPMA-bound doxorubicin on mouse EL4 T-cell lymphomaBlanka Říhová, Tomáš Etrych, Milada Šírová, et al.
Oncoimmunology|June 23, 2017
Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cellsIrena Adkins, Lenka Sadilkova, Nada Hradilova, et al.
International Journal of Cancer|December 18, 2010
Antitumor activity of IL-2/anti-IL-2 mAb immunocomplexes exerts synergism with that of N-(2-hydroxypropyl)methacrylamide copolymer-bound doxorubicin conjugate due to its low immunosuppressive activityJakub Tomala, Helena Chmelova, Jiri Strohalm, et al.
Journal of Biomedical Nanotechnology|October 22, 2015
Novel IL-2-Poly(HPMA)Nanoconjugate Based ImmunotherapyPetra Votavova, Jakub Tomala, Vladimir Subr, et al.
Pageof 4